AbCellera Biologics Inc. (ABCL) Most Active Options

The 25 most actively traded AbCellera Biologics Inc. (ABCL) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.

Data as of Oct 12, 2026, 3:55 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close
$12.68
52-week range
$2.76 – $14.82
IV rank
9 / 100
Low
Put/call OI
0.51
Call-heavy
Max pain
$7
↓ 44.8% below close
Next earnings
Nov 5, 2026

Chat with OptAI about ABCL


Most Active ABCL Contracts

ContractExpirationDTELastIV IV rank (30d)DeltaOpen interestVolumevs 30d avg
ABCL $13 call Oct 16, 2026 4d $0.35 90.4% 100 0.40 5,682 194 0.6× avg
ABCL $12 call Jan 15, 2027 95d $2.30 91.0% 96 0.64 4,966 144 2.6× avg
ABCL $14 call Nov 20, 2026 39d $0.90 87.7% 50 0.42 575 105 1.0× avg
ABCL $11 put Oct 16, 2026 4d $0.07 128.9% 0 -0.14 3,065 93 6.0× avg
ABCL $13 call Nov 20, 2026 39d $1.30 84.1% 40 0.52 1,475 76 0.3× avg
ABCL $15 call Oct 16, 2026 4d $0.05 111.1% 100 0.08 2,850 57 0.4× avg
ABCL $14 call Oct 16, 2026 4d $0.05 93.6% 44 0.16 2,186 46 0.3× avg
ABCL $15 call Nov 20, 2026 39d $0.60 92.4% 69 0.34 1,296 32 0.3× avg
ABCL $11 call Jan 15, 2027 95d $2.90 89.1% 76 0.71 317 28 1.0× avg
ABCL $16 call Nov 20, 2026 39d $0.45 91.1% 70 0.26 838 25 0.4× avg
ABCL $10 call Jan 15, 2027 95d $3.70 79.9% 48 0.79 5,424 25 0.9× avg
ABCL $14 call Jan 15, 2027 95d $1.50 81.5% 56 0.49 351 21 0.6× avg
ABCL $10 put Apr 16, 2027 186d $1.36 83.1% 37 -0.23 4 20 4.6× avg
ABCL $18 call Nov 20, 2026 39d $0.28 87.0% 55 0.14 1,126 17 0.3× avg
ABCL $12 call Oct 16, 2026 4d $0.91 106.3% 100 0.70 2,057 17 1.1× avg
ABCL $12 put Oct 16, 2026 4d $0.15 75.7% 0 -0.24 5,837 16 0.1× avg
ABCL $13 call Apr 16, 2027 186d $3.00 79.2% 66 0.61 125 16 0.2× avg
ABCL $9 put Jan 15, 2027 95d $0.50 84.1% 5 -0.15 4,502 15 2.8× avg
ABCL $15 call Jan 15, 2027 95d $1.30 82.5% 59 0.43 3,095 14 0.4× avg
ABCL $10 put Nov 20, 2026 39d $0.35 86.3% 31 -0.16 211 13 1.5× avg
ABCL $13 put Oct 16, 2026 4d $0.50 78.7% 100 -0.62 2,821 12 1.6× avg
ABCL $17 call Nov 20, 2026 39d $0.45 89.1% 63 0.20 593 12 0.2× avg
ABCL $8 call Oct 16, 2026 4d $4.90 307.0% 17 0.94 2,008 11 9.0× avg
ABCL $27 call Jan 19, 2029 830d $3.72 80.4% 20 0.52 88 11 1.2× avg
ABCL $9 put Oct 16, 2026 4d $0.22 235.1% 10 -0.07 418 10 5.0× avg

Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.

The most active ABCL contract today is the $13 call expiring in 4 days, with 194 contracts traded. Calls dominate the most-active list (18 of the top 25), showing where trading interest concentrates.

Explore the payoff profile of option on ABCL for free

Build multi-leg ABCL strategies, visualize payoffs, and scan the full US options universe with OptiView.

ABCL Options FAQ

Which ABCL option contract is most active today?

The most traded ABCL contract is the $13 call expiring Oct 16, 2026, with 194 contracts traded as of Oct 12, 2026.

How does OptiView rank the most active ABCL options?

The table lists the 25 ABCL contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.